A study published in the European Journal of Neuroscience found that a synthetic cannabinoid reduced intraocular pressure in eight glaucoma patients for whom mainstream treatments failed.
This confirms the experience of Elvy Musikka and Robert Randall, two glaucoma patients who receive med-pot from the US government.
– European Journal of Neuroscience synergy abstract: .blackwell-synergy.com/Journals/processfree2.asp?contentid=ejn.2001.2&filetype=abstracts&article=86244&year=&journal
– Glaucoma Questions and Answers: www.lighthouse.org/resources_glaucoma.htm
